Clinical outcome for gastrointestinal cancers with polymerase epsilon mutations treated with immunotherapy.

828Background: Predictive factors for immunotherapy benefit across gastrointestinal (GI) cancers are limited to those with deficient mismatch repair (dMMR). Mutations in DNA polymerase E (POLE) can...